Newsletter Journal Club |
Publishing date: July 2019
Author(s): Hirooka K (1), Nitta E (2), Ukegawa K (2), Sato S (2), Kiuchi Y (3)
1 Ophthalmology and Visual Science, Hiroshima University, Hiroshima, Japan khirooka9@gmail.com.
2 Ophthalmology, Kagawa University, Miki, Japan.
3 Ophthalmology and Visual Science, Hiroshima University, Hiroshima, Japan.
AIM: To investigate changes in corneal endothelial cell density (CECD) after trabeculectomy.
METHODS: This prospective, observational study followed 117 eyes of 117 patients for 2 years after trabeculectomy. The central cornea was examined by corneal specular microscopy prior to and at every 6 months after the surgery. Survival analysis of patients who exhibited a 10% or less reduction of the postoperative CECD compared with preoperative levels was assessed using the Kaplan-Meier survival curve. A Cox proportional hazards model was used to evaluate prognostic factors for decreasing CECD.
RESULTS: At baseline, the mean CECD was 2420±357 cells/mm2, while at 6, 12, 18 and 24 months after surgery, the mean CECD was 2324±373 cells/mm2 (p<0.001), 2276±400 cells/mm2 (p<0.001), 2290±398 cells/mm2 (p<0.001) and 2267±446 cells/mm2 (p<0.001), respectively. At 6, 12, 18 and 24 months after surgery, the results of the Kaplan-Meier survival analysis of the 10% loss of CECD from baseline were 91%, 85%, 83% and 77%, respectively. Uveitic glaucoma was a significant prognostic factor for decreasing CECD (p=0.041).
CONCLUSIONS: CECD significantly and continuously decreased after trabeculectomy.
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Br J Ophthalmol. 2019 Jun 14. pii: bjophthalmol-2018-313417. doi: 10.1136/bjophthalmol-2018-313417.
http://www.ncbi.nlm.nih.gov/pubmed/31201168
Keywords: cornea, glaucoma, treatment surgery
Clinical Paper of the Month manager: Andreas Boehm
